In a nested case-control study, Krzyzanowska et al. [86] reported higher plasma visfatin in GDM women compared to controls with normal glucose tolerance, but there was no relationship with fasting plasma glucose, insulin, insulin resistance or BMI. This evidence concerns the gene NAMPT and Insulin resistance.